LABP Stock Earnings: Landos Biopharma Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

LABP stock results show that Landos Biopharma missed analyst estimates for earnings per share the fourth quarter of 2023.

The post LABP Stock Earnings: Landos Biopharma Misses EPS for Q4 2023 appeared first on InvestorPlace.

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• “America’s Top Trader” Issues A.I. Code Red: Act Now or Miss Out
• It doesn’t matter if you have $500 or $5 million. Do this now.